Media center
STATEMENT: Toy water beads recalled, parents should be wary of other beads
CoPIRG applauds Gov. Polis’s sustainability executive order, commitment to reduce air pollution from lawn equipment
STATEMENT: Biden administration takes steps to protect Arctic from drilling
Contact our media team
Mark Morgenstein
Director of Media Relations, The Public Interest Network [email protected]
Are you a member of the media?
Join our media list
Topic/Campaign
Type
Clean air board votes to stop the sale of the dirtiest gas-powered lawn tools in Denver region by 2025
A gas-powered leaf blower produces as much ozone-forming pollution in one hour as driving 1,100 miles, fueling region's dirty air days
News release: Airline cancellations could skyrocket July 1 as 5G technology thwarts some landings
Travelers should plan ahead and know their rights if their flight is canceled or delayed in a week already marred by disruptions.
STATEMENT: Publishers Clearing House settles FTC lawsuit over deception
Second FTC case in a week alleging ‘dark patterns’ used to trick consumers
NEW REPORT: Electric Vehicles Save Money for Government Fleets
Data shows taxpayer, air quality benefits of transitioning from gasoline, diesel-powered vehicles to EVs
Story Idea: Online sales of counterfeit, stolen products should decline under new law
INFORM Act expected to help consumers by reducing volume of items sold illegally
NEWS RELEASE: Parents, environmentalists to Google: stop Chromebooks from expiring this summer
End of service for millions of school computers jeopardizes students’ educations
STATEMENT: Ticketmaster, Airbnb, SeatGeek promise to end surprise junk fees
When some businesses don’t disclose all fees, it hurts consumers and companies that do
With Memorial Day picnics and barbecues on deck, how to make sure your food is safe
New PIRG analysis of FDA, USDA data show recalls from Salmonella doubled in 2022
NEWS RELEASE: Fake tickets for Taylor Swift, Beyonce, lead to broken hearts, empty wallets
Con artists hope concert, sports fans will fall for sophisticated scams
SCOTUS action will limit generic drug competition
U.S. Supreme Court on Monday declined to review a federal circuit court decision that imperils a critical method that many generic drug makers use to win approval. The court denied a petition of certiorari in Teva Pharmaceuticals USA, Inc. V GlaxoSmithKline LLC, Et. Al., allowing the divided lower court's decision to stand. This action can have dramatically limit competition from lower-priced generic and biosimilar medicines.